Live from the NIH registry
Studies recruiting near Burlington right now
Top 25 of 759 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Cone Health Cancer Center at Alamance Regional — Burlington, North Carolina (2.2 mi)
· Sponsor: SWOG Cancer Research Network
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
UNC Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: National Cancer Institute (NCI)
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
HER2-positive Metastatic Breast Cancer
N/A
Observational 200 participants sought
UNC Chapel Hill — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Abramson Cancer Center at Penn Medicine
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
Chapel Hill — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Westat
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
UNC- Chapel Hill — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Guardant Health, Inc.
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Headache Wellness Center /ID# 270568 — Greensboro, North Carolina (18.1 mi)
· Sponsor: AbbVie
Medically Tailored Meals for Kids
Pediatric Cancer
N/A
Interventional 30 participants sought
North Carolina Basnight Cancer Hospital — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: UNC Lineberger Comprehensive Cancer Center
Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
Heart Failure
N/A
Interventional 1,200 participants sought
Cone Health — Greensboro, North Carolina (18.1 mi)
· Sponsor: Analog Device, Inc.
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 4
Interventional 65 participants sought
University of North Carolina — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Takeda
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Cone Health Cancer Center at Alamance Regional — Burlington, North Carolina (2.2 mi)
· Sponsor: NRG Oncology
The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias
Relapsed or Resistant Acute Leukaemias
Phase 1, Phase 2
Interventional 90 participants sought
UNC Hospitals, The University of North Carolina at Chapel Hill — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Lin BioScience, Inc
Improving Thoracic Surgical Care Using Electronic Patient-Reported Outcomes (ePROS)
Thoracic
N/A
Interventional 200 participants sought
Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: UNC Lineberger Comprehensive Cancer Center
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
N/A
Observational 3,000 participants sought
Pulmonix LLC — Greensboro, North Carolina (18.1 mi)
· Sponsor: Duke University
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
Acute HIV Infection
Phase 2
Interventional 48 participants sought
3203, Greensboro CRS — Greensboro, North Carolina (18.1 mi)
· Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Urothelial Carcinoma, Urothelial Carcinoma Recurrent
N/A
Observational 400 participants sought
The University of North Carolina Chapel Hill — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: UroGen Pharma Ltd.
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Lewy Body Dementia Psychosis
Phase 2
Interventional 180 participants sought
UNC Hospitals — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: ACADIA Pharmaceuticals Inc.
Rotator Cuff Repairs With or Without BioEnthesis™ Augmentation
Rotator Cuff Tears, Rotator Cuff Injuries
Phase 4
Interventional 100 participants sought
University of North Carolina Chapel Hill — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Brooke Army Medical Center
Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes: A Pragmatic SMART
Diabetes type1, Diabetes Mellitus, Type 1
N/A
Interventional 200 participants sought
University of North Carolina at Chapel Hill — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: University of North Carolina, Chapel Hill
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 3
Interventional 59 participants sought
University of North Carolina (UNC) — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Takeda
Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial
Preterm Delivery, Obstetrical Complications
Phase 3
Interventional 1,800 participants sought
University of North Carolina - Chapel Hill — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: The George Washington University Biostatistics Center
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Cystic Fibrosis
N/A
Observational 400 participants sought
University of North Carolina at Chapel Hill — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Nicole Hamblett
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Cardiovascular Disease and Lipoprotein(a)
Phase 3
Interventional 5,700 participants sought
Medication Management LLC — Greensboro, North Carolina (18.1 mi)
· Sponsor: Novartis Pharmaceuticals
Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)
Leukemia, Acute Leukemia
N/A
Interventional 40 participants sought
University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: UNC Lineberger Comprehensive Cancer Center
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
Tuberous Sclerosis Complex, Epilepsy
Phase 2
Interventional 64 participants sought
University of North Carolina at Chapel Hill — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Darcy Krueger
The Osteoarthritis Prevention Study
Osteoarthritis, Knee
N/A
Interventional 1,230 participants sought
University of North Carolina at Chapel Hill — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Wake Forest University